Drug Type Small molecule drug |
Synonyms AIR-001 |
Target- |
Mechanism Nitric oxide donors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute decompensated heart failure | Phase 2 | US | 11 Mar 2018 | |
Acute decompensated heart failure | Phase 2 | US | 11 Mar 2018 | |
Hypertension, Pulmonary | Phase 2 | US | 11 Mar 2018 | |
Pseudomonas Infections | Phase 2 | US | 11 Mar 2018 | |
Pseudomonas Infections | Phase 2 | US | 11 Mar 2018 | |
Pulmonary Arterial Hypertension | Phase 2 | CZ | 28 Feb 2017 | |
Pulmonary Arterial Hypertension | Phase 2 | DE | 28 Feb 2017 | |
Pulmonary Arterial Hypertension | Phase 2 | PL | 28 Feb 2017 |
Phase 2 | 26 | Placebo (Placebo (Saline)) | xojxvbyxkg(frvkavbjsq) = dkgvvvjepp tyfngjiphg (zgnmdgicxk, reqhoczoec - xalarbbavg) View more | - | 19 Jan 2017 | ||
Sodium Nitrite Inhalation Solution (Sodium Nitrite) | xojxvbyxkg(frvkavbjsq) = kidrsnzcdo tyfngjiphg (zgnmdgicxk, qxncnwjrwv - vdvrhjamhs) View more |